The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions DOI Creative Commons
Abdelhakim Bouyahya, Hamza Mechchate, Loubna Oumeslakht

et al.

Biomolecules, Journal Year: 2022, Volume and Issue: 12(3), P. 367 - 367

Published: Feb. 25, 2022

Cancer is a complex disease resulting from the genetic and epigenetic disruption of normal cells. The mechanistic understanding pathways involved in tumor transformation has implicated priori predominance perturbations posteriori instability. In this work, we aimed to explain involvement cancer process, as well abilities natural bioactive compounds isolated medicinal plants (flavonoids, phenolic acids, stilbenes, ketones) specifically target epigenome molecular events leading transformation, angiogenesis, dissemination are often complex, stochastic, take turns. On other hand, decisive advances genomics, epigenomics, transcriptomics, proteomics have allowed, recent years, for decryption cancerization process. This could possibility targeting or that mechanism cancerization. With plasticity flexibility modifications, some studies started pharmacological screening substances against different (DNA methylation, histone acetylation, chromatin remodeling) restore cellular memory lost during transformation. These can inhibit DNMTs, modify remodeling, adjust modifications favor pre-established cell identity by differentiation program. Epidrugs molecules program therefore cancerous diseases. Natural products such flavonoids acids shown their ability exhibit several actions on modifiers, inhibition DNMT, HMT, HAT. mechanisms these specific pleiotropic sometimes be use anticancer epidrugs currently remarkable avenue fight human cancers.

Language: Английский

The molecular hallmarks of epigenetic control DOI
C. David Allis, Thomas Jenuwein

Nature Reviews Genetics, Journal Year: 2016, Volume and Issue: 17(8), P. 487 - 500

Published: June 27, 2016

Language: Английский

Citations

2325

Erasers of Histone Acetylation: The Histone Deacetylase Enzymes DOI Open Access

Ed Seto,

Minoru Yoshida

Cold Spring Harbor Perspectives in Biology, Journal Year: 2014, Volume and Issue: 6(4), P. a018713 - a018713

Published: April 1, 2014

Edward Seto1 and Minoru Yoshida2 1Department of Molecular Oncology, Moffitt Cancer Center Research Institute, Tampa, Florida 33612 2Chemical Genetics Laboratory, RIKEN, Wako, Saitama 351-0198, Japan Correspondence: ed.seto{at}moffitt.org

Language: Английский

Citations

1693

Epigenetic Determinants of Cancer DOI Open Access
Stephen B. Baylin, Peter A. Jones

Cold Spring Harbor Perspectives in Biology, Journal Year: 2016, Volume and Issue: 8(9), P. a019505 - a019505

Published: May 18, 2016

Stephen B. Baylin1 and Peter A. Jones2 1Cancer Biology Program, Johns Hopkins University, School of Medicine, Baltimore, Maryland 21287 2Van Andel Research Institute, Grand Rapids, Michigan 49503 Correspondence: sbaylin{at}jhmi.edu

Language: Английский

Citations

1091

Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials DOI Creative Commons
Yuan Cheng, He Cai, Manni Wang

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2019, Volume and Issue: 4(1)

Published: Dec. 17, 2019

Epigenetic alternations concern heritable yet reversible changes in histone or DNA modifications that regulate gene activity beyond the underlying sequence. dysregulation is often linked to human disease, notably cancer. With development of various drugs targeting epigenetic regulators, epigenetic-targeted therapy has been applied treatment hematological malignancies and exhibited viable therapeutic potential for solid tumors preclinical clinical trials. In this review, we summarize aberrant functions enzymes methylation, acetylation methylation during tumor progression highlight inhibitors targeted at enzymes.

Language: Английский

Citations

900

Histone Modifications and Cancer DOI Open Access
James E. Audia, Robert M. Campbell

Cold Spring Harbor Perspectives in Biology, Journal Year: 2016, Volume and Issue: 8(4), P. a019521 - a019521

Published: April 1, 2016

Histone posttranslational modifications represent a versatile set of epigenetic marks involved not only in dynamic cellular processes, such as transcription and DNA repair, but also the stable maintenance repressive chromatin. In this article, we review many key newly identified histone known to be deregulated cancer how impacts function. The latter part article addresses challenges current status drug development process it applies therapeutics.

Language: Английский

Citations

839

50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond DOI
Eric Verdin, Mélanie Ott

Nature Reviews Molecular Cell Biology, Journal Year: 2014, Volume and Issue: 16(4), P. 258 - 264

Published: Dec. 30, 2014

Language: Английский

Citations

775

Epigenetics and epigenomics in diabetic kidney disease and metabolic memory DOI
Mitsuo Kato, Rama Natarajan

Nature Reviews Nephrology, Journal Year: 2019, Volume and Issue: 15(6), P. 327 - 345

Published: March 20, 2019

Language: Английский

Citations

456

Epigenetic modifications of histones in cancer DOI Creative Commons
Zibo Zhao, Ali Shilatifard

Genome biology, Journal Year: 2019, Volume and Issue: 20(1)

Published: Nov. 20, 2019

Abstract The epigenetic modifications of histones are versatile marks that intimately connected to development and disease pathogenesis including human cancers. In this review, we will discuss the many different types histone biological processes with which they involved. Specifically, review enzymatic machineries involved in cancer progression, how apply currently available small molecule inhibitors for modifiers as tool compounds study functional significance their clinical implications.

Language: Английский

Citations

454

Histone deacetylase 6 structure and molecular basis of catalysis and inhibition DOI
Yang Hai, D.W. Christianson

Nature Chemical Biology, Journal Year: 2016, Volume and Issue: 12(9), P. 741 - 747

Published: July 25, 2016

Language: Английский

Citations

425

Epigenetic Regulation in Plants DOI Open Access
Craig S. Pikaard, Ortrun Mittelsten Scheid

Cold Spring Harbor Perspectives in Biology, Journal Year: 2014, Volume and Issue: 6(12), P. a019315 - a019315

Published: Dec. 1, 2014

Craig S. Pikaard1 and Ortrun Mittelsten Scheid2 1Department of Biology, Department Molecular Cellular Biochemistry, Howard Hughes Medical Institute, Indiana University, Bloomington, 47405 2Gregor Mendel-Institute Plant Austrian Academy Sciences, 1030 Vienna, Austria Correspondence: ortrun.mittelsten_scheid{at}gmi.oeaw.ac.at

Language: Английский

Citations

378